IL1B and colitis: LAG-3 on Tregs was also highlighted in an innate-like cell 3-driven experimental inflammatory model of colitis, where LAG-3+ Tregs specifically targeted CX3CR1+ macrophages, decreasing their production of IL-23 and IL-1β, ameliorating disease54.